Drawing for TENDOFLEX

USPTO serial 88411516

TENDOFLEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
STURMAN, MELISSA M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TENDOFLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joseph V. Myers III

Joseph V. Myers III SEYFARTH SHAW LLP1075 PEACHTREE STREET, SUITE 2500ATLANTA, GA 30309UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Natural dietary supplements in the form of capsules, tablets and gelcaps for joint pain, namely, tendonitis, tendinopathy, shoulder pain associated with tendonitis, elbow pain associated with tendonitis, leg and ankle pain associated with Achilles tendonitis, foot pain associated with plantar fasciitisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 5, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 5, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 3, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 2, 2022EX5GSOU EXTENSION 5 GRANTED—
May 2, 2022AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 26, 2022EXT5SOU EXTENSION 5 FILED—
Apr 26, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 30, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 28, 2021EX4GSOU EXTENSION 4 GRANTED—
Sep 28, 2021EXT4SOU EXTENSION 4 FILED—
Sep 28, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 24, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 22, 2021EX3GSOU EXTENSION 3 GRANTED—
Apr 22, 2021EXT3SOU EXTENSION 3 FILED—
Apr 22, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 24, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 22, 2020EX2GSOU EXTENSION 2 GRANTED—
Oct 22, 2020EXT2SOU EXTENSION 2 FILED—
Oct 22, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 30, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 28, 2020EX1GSOU EXTENSION 1 GRANTED—
Apr 28, 2020EXT1SOU EXTENSION 1 FILED—
Apr 28, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 14, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 29, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 3, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 3, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 14, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 29, 2019ALIEASSIGNED TO LIE—
Jul 18, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 18, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Jul 18, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 18, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 18, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 14, 2019DOCKASSIGNED TO EXAMINER—
May 18, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 4, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance